Almost 35% of drugs approved by the Food and Drug Administration work by targeting G protein-coupled receptors (GPCRs), proteins embedded in cell membranes that allow cells to communicate with each ...

Almost 35% of drugs approved by the Food and Drug Administration work by targeting G protein-coupled receptors (GPCRs), ...

It is possible to substantially enhance these antibodies’ therapeutic potential via humanization, effectively reducing ...

Australian-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has ...

Infectious or chronic diseases such as long COVID, Alzheimer’s disease and traumatic brain injury can cause inflammation in ...

Researchers from the Children’s Hospital of Philadelphia (CHOP) and Stanford University have unveiled the molecular structure ...

Researchers from Children's Hospital of Philadelphia (CHOP) and Stanford University have revealed the molecular ...

Researchers from Children's Hospital of Philadelphia (CHOP) and Stanford University have revealed the molecular structure of ...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call Transcript December 10 ... I have voluntarily agreed to ...

Scientists have developed a way to deliver radiation just to cancerous cells; the therapy combines a drug to mark the cancer ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney ...